Related Experiment Video
Updated: Dec 18, 2025

Synthesis of 1,2-Azaborines and the Preparation of Their Protein Complexes with T4 Lysozyme Mutants
Published on: March 25, 2017
Synthesis and biological evaluation of arylphosphonium-benzoxaborole conjugates as novel anticancer agents
Sravan K Jonnalagadda1, Kevin Wielenberg2, Conor T Ronayne1
1Integrated Biosciences Graduate Program, University of Minnesota, Duluth, MN 55812, USA.
Abstract:
Arylphosphonium-benzoxaborole conjugates have been synthesized as potential mitochondria targeting anticancer agents. The synthesized compounds have been tested for their effects on cell viability in various solid tumor cell lines including breast cancer 4T1 and MCF-7, pancreatic cancer MIAPaCa-2 and colorectal adenocarcinoma WiDr. Compound 6c is designated as a lead compound for further studies due to its enhanced effects on cell viability in the above-mentioned cell lines. Seahorse Xfe96 based metabolic assays reveal that the lead candidate 6c inhibits mitochondrial respiration in 4T1 and WiDr cell lines as evidenced by the reduction of mitochondrial ATP production and increase in proton leak. Epiflourescent microscopy experiments also illustrate that 6c causes significant mitochondrial fragmentation in 4T1 and WiDr cells, morphologically consistent with programmed cell death. Our current studies illustrate that arylphosphonium-benzoxaborole conjugates have potential to be further developed as anticancer agents.
Insights
New arylphosphonium-benzoxaborole conjugates show promise as mitochondria-targeting anticancer agents. Lead compound 6c effectively reduced cancer cell viability and inhibited mitochondrial respiration.
Area of Science:
- Medicinal Chemistry
- Cancer Biology
- Mitochondrial Biology
Background:
- Mitochondria are crucial targets for anticancer drug development.
- Arylphosphonium-benzoxaborole conjugates offer a novel scaffold for drug design.
Purpose of the Study:
- To synthesize and evaluate arylphosphonium-benzoxaborole conjugates as mitochondria-targeting anticancer agents.
- To identify a lead compound for further preclinical development.
Main Methods:
- Synthesis of arylphosphonium-benzoxaborole conjugates.
- In vitro cell viability assays on breast, pancreatic, and colorectal cancer cell lines.
- Seahorse Xfe96 metabolic assays to assess mitochondrial respiration.
- Epifluorescent microscopy to evaluate mitochondrial morphology.
Main Results:
- Compound 6c demonstrated significant cytotoxicity across multiple solid tumor cell lines.
- Lead compound 6c inhibited mitochondrial respiration, reducing ATP production and increasing proton leak in 4T1 and WiDr cells.
- 6c induced mitochondrial fragmentation, indicative of programmed cell death.
Conclusions:
- Arylphosphonium-benzoxaborole conjugates represent a promising class of mitochondria-targeting anticancer agents.
- Compound 6c warrants further investigation as a potential therapeutic candidate for solid tumors.
Related Concept Videos
Electrophilic Aromatic Substitution: Chlorination and Bromination of Benzene
Electrophilic Aromatic Substitution: Fluorination and Iodination of Benzene
Nucleophilic Aromatic Substitution of Aryldiazonium Salts: Aromatic SN1
In the Sandmeyer reaction, for example, the diazonio group is replaced by a chloro, bromo,...
Physical Properties of Amines
Nucleophilic Aromatic Substitution: Elimination–Addition
Phase II Reactions: Miscellaneous Conjugation Reactions
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...

